News

ILiAD Biotechnologies

June 2019 ILIAD Biotechnologies BPZE1 vaccine mentioned in CNN Report: Whooping cough vaccine becomes less effective over time, study says

ILiAD Biotechnologies

2018 ILiAD Biotechnologies Secures Up to $20 million of Financing and Phase 2a BPZE1 Pertussis Vaccine Trial Initiates at Vanderbilt University Medical Center
Read the full press release

GPB Scientific

2018 GPB Scientific closes $2.5 million convertible note round

FORGE Life Sciences

Fall 2017 FORGE Life Sciences raises $500,000 from angel investors

Illuminare Biotechnologies

Summer 2017 Illuminare Biotechnologies closed a $2.3M Series A round

ILiAD Biotechnologies

July 2017 ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study Data
Read the full press release...

RenalSense

2017-2018 RenalSense raises $3.5 million from angel investors

GPB Scientific

2017 GPB Scientific raises $1.0 million from angel investors

ILiAD Biotechnologies

2016-2017 ILiAD Biotechnologies raises $2.6 million from angel investors

GPB Scientific

Spring 2016 GPB Scientific raises $1.0 million from angel investors.

ILiAD Biotechnologies

Spring 2016 ILiAD Biotechnologies raises $1.0 million from angel investors.

GPB Scientific

Fall 2015 GPB Scientific closes $1.6 million Series A round.

RenalSense

Fall 2015 RenalSense closes $3.6 million Series A round.

ILiAD Biotechnologies

Fall 2015 ILiAD Biotechnologies closes $3.7 million financing round.

CytoSorbents Corporation

March 2014 CytoSorbents Corporation Announces $10.2 Million Registered Direct Offering.
Click here to read the full press release

GPB Scientific

March 2014 GPB Scientific raises $700,000 from angel investors.

Callidus Biopharma

November 2013 Callidus Biopharma acquired by Amicus Therapeutics (NASDAQ-FOLD) for $15 million upfront payment with potential milestone payments totaling $115 million. Click here to read the full press release

Hygeia Therapeutics

November 2013 Hygeia Therapeutics acquired by Stratus Media Group (OTCBB-SMDI).
Click here to read the full press release

CytoSorbents

October 2013 CytoSorbents raises $200,000 from angel investors.

Callidus Biopharma

May 2013 Callidus Biopharma announces $4.6 million Series A financing
Read the full press release

Callidus Biopharma

March 2013 Callidus Biopharma receives $3.0 million from strategic investors

Callidus Biopharma

December 2012 Callidus Biopharma successfully generates in vivo proof of concept data

Callidus Biopharma

January 2012 Callidus Biopharma receives $1.6 million from Angel and strategic investors

Core Essence Orthopaedics

October 2011 Core Essence Orthopaedics launches PONTiS™, a novel endotendonous implant for minimally invasive repair of severed tendons

Lerner Medical Devices

September 2011 Lerner Medical Devices closes on a $1M Angel financing

Advanced BioHealing

July 2011 Advanced BioHealing Acquired by Shire Pharmaceuticals for $750M

WuXi PharmaTech

June 2011 WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise by China's Ministry of Commerce

Core Essence Orthopaedics

March 2011 Core Essence Orthopaedics receives an $11.3M Series B round led by Baird Venture Partners

WuXi PharmaTech

March 2011 WuXi PharmaTech announces collaboration with BMS for a new analytical and stability testing facility

Core Essence Orthopaedics

October 2010 Core Essence Orthopaedics closes on a $2.9M Convertible Debt from Angel Investors

QuantumBio and Chemical Computing Group

May 2011 QuantumBio and Chemical Computing Group announce release of DivCon Discovery Suite for MOE

Hygeia Therapeutics

March 2010 Hygeia Therapeutics closes on a $2.0M round from Angel Investors

Lerner Medical Devices

November 2009 Lerner Medical Devices receives 510(k) clearance for Levia® Targeted Phototherapy for Self-Treatment at home

WuXi PharmaTech

October 2009 WuXi PharmaTech receives 2009 Schering-Plough Excellence Award

Lerner Medical Devices

December 2007 Lerner Medical Devices closes on a $3.3M Angel Round to develop Levia® device

WuXi PharmaTech

2007 WuXi PharmaTech publicily listed in NYSE. Read More